299 related articles for article (PubMed ID: 7929473)
21. The secretion of catecholamines, chromogranin A and neuropeptide Y from the adrenal medulla of the cat via the adrenolumbar vein and thoracic duct: different anatomic routes based on size.
Carmichael SW; Stoddard SL; O'Connor DT; Yaksh TL; Tyce GM
Neuroscience; 1990; 34(2):433-40. PubMed ID: 2333152
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous secretion of catecholamines from the adrenal medulla and of [3H]norepinephrine from sympathetic nerves from a single test preparation: different effects of agents on the secretion.
Wakade AR; Malhotra RK; Wakade TD; Dixon WR
Neuroscience; 1986 Aug; 18(4):877-88. PubMed ID: 3762930
[TBL] [Abstract][Full Text] [Related]
23. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
[TBL] [Abstract][Full Text] [Related]
24. Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.
Pasqua T; Mahata S; Bandyopadhyay GK; Biswas A; Perkins GA; Sinha-Hikim AP; Goldstein DS; Eiden LE; Mahata SK
Cell Tissue Res; 2016 Mar; 363(3):693-712. PubMed ID: 26572539
[TBL] [Abstract][Full Text] [Related]
25. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
Lundberg JM; Rudehill A; Sollevi A; Hamberger B
Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
[TBL] [Abstract][Full Text] [Related]
26. The counterregulatory response to hypoglycaemia in women with the polycystic ovary syndrome.
Gennarelli G; Holte J; Stridsberg M; Niklasson F; Berne C; Bäckström T
Clin Endocrinol (Oxf); 1997 Feb; 46(2):167-74. PubMed ID: 9135698
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.
Todorov LD; Mihaylova-Todorova S; Craviso GL; Bjur RA; Westfall DP
J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):731-48. PubMed ID: 8930840
[TBL] [Abstract][Full Text] [Related]
28. Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.
Hsiao RJ; Parmer RJ; Takiyyuddin MA; O'Connor DT
Medicine (Baltimore); 1991 Jan; 70(1):33-45. PubMed ID: 1988765
[TBL] [Abstract][Full Text] [Related]
29. [3H]noradrenaline accumulation in cultured bovine adrenal medullary cells: modulation of accumulation by nicotine.
McKay DB
Naunyn Schmiedebergs Arch Pharmacol; 1989 Dec; 340(6):610-6. PubMed ID: 2615853
[TBL] [Abstract][Full Text] [Related]
30. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
Hemsén A; Pernow J; Millberg BI; Lundberg JM
Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
[TBL] [Abstract][Full Text] [Related]
31. Circulating neuropeptide Y (NPY) and catecholamines in rat under resting and stress conditions. Arguments for extra-adrenal origin of NPY, adrenal and extra-adrenal sources of catecholamines.
Bernet F; Dedieu JF; Laborie C; Montel V; Dupouy JP
Neurosci Lett; 1998 Jun; 250(1):45-8. PubMed ID: 9696062
[TBL] [Abstract][Full Text] [Related]
32. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats.
Zukowska-Grojec Z; Konarska M; McCarty R
Life Sci; 1988; 42(17):1615-24. PubMed ID: 3367684
[TBL] [Abstract][Full Text] [Related]
33. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
34. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
Lacroix JS; Stjärne P; Anggärd A; Lundberg JM
Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
[TBL] [Abstract][Full Text] [Related]
35. Modulation of noradrenaline and neuropeptide Y (NPY) release in the pig kidney in vivo: involvement of alpha 2, NPY and angiotensin II receptors.
Pernow J; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):379-85. PubMed ID: 2555719
[TBL] [Abstract][Full Text] [Related]
36. Co-release of neuropeptide Y and catecholamines upon adrenal activation in the cat.
Lundberg JM; Fried G; Pernow J; Theodorsson-Norheim E
Acta Physiol Scand; 1986 Feb; 126(2):231-8. PubMed ID: 3754683
[TBL] [Abstract][Full Text] [Related]
37. Chromogranin A deficiency in transgenic mice leads to aberrant chromaffin granule biogenesis.
Kim T; Zhang CF; Sun Z; Wu H; Loh YP
J Neurosci; 2005 Jul; 25(30):6958-61. PubMed ID: 16049171
[TBL] [Abstract][Full Text] [Related]
38. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
[TBL] [Abstract][Full Text] [Related]
39. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.
Cavadas C; Céfai D; Rosmaninho-Salgado J; Vieira-Coelho MA; Moura E; Busso N; Pedrazzini T; Grand D; Rotman S; Waeber B; Aubert JF; Grouzmann E
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10497-10502. PubMed ID: 16798884
[TBL] [Abstract][Full Text] [Related]
40. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.
Parmer RJ; Mahata M; Gong Y; Mahata SK; Jiang Q; O'Connor DT; Xi XP; Miles LA
J Clin Invest; 2000 Oct; 106(7):907-15. PubMed ID: 11018079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
